Stocktoria

Galenica AG GALE.SW

CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website

Galenica AG financials (annual)

Revenue
2022202320242025
Net income
2022202320242025
Free cash flow
2022202320242025

Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022
RevenueCHF 4.1BCHF 3.9BCHF 3.7BCHF 3.6B
Gross profitCHF 1.2BCHF 1.1BCHF 1.0BCHF 985.3M
SG&A expenseCHF 82.6MCHF 82.9MCHF 99.6MCHF 82.1M
Operating incomeCHF 226.2MCHF 204.4MCHF 189.9MCHF 186.0M
Interest expenseCHF 13.5MCHF 12.7MCHF 9.5MCHF 5.2M
Income taxCHF 38.5MCHF 30.9MCHF 29.2MCHF 32.3M
Net incomeCHF 181.1MCHF 183.0MCHF 285.4MCHF 165.1M
EPS (diluted)CHF 3.63CHF 3.67CHF 5.72CHF 3.32
Operating cash flowCHF 299.8MCHF 264.7MCHF 225.7MCHF 236.9M
Free cash flowCHF 244.0MCHF 192.3MCHF 149.3MCHF 167.1M
Cash & equivalentsCHF 115.5MCHF 129.7MCHF 116.2MCHF 93.9M
InventoryCHF 385.4MCHF 363.1MCHF 357.1MCHF 315.2M
GoodwillCHF 1.0BCHF 891.5MCHF 871.3MCHF 914.7M
Total assetsCHF 3.3BCHF 3.1BCHF 3.0BCHF 2.6B
Total debtCHF 244.0MCHF 235.9MCHF 236.0MCHF 233.2M
Total liabilitiesCHF 1.8BCHF 1.5BCHF 1.5BCHF 1.4B
Shareholders' equityCHF 1.5BCHF 1.5BCHF 1.5BCHF 1.2B
Share buybacksCHF 14.0MCHF 9.7MCHF 11.0MCHF 539,000

Growth · year-over-year · Revenue CAGR 4.8%

MetricFY2025FY2024FY2023FY2022
Revenue growth+5.5%+4.7%+4.4%—
Net income growth-1.0%-35.9%+72.8%—
EPS growth-1.1%-35.8%+72.3%—
Free cash flow growth+26.9%+28.8%-10.6%—

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · CH · as of 2025-12-31. Figures in CHF. Facts plus Stocktoria's own computed scores — not investment advice.